CSLZ alleviates colitis-associated inflammation by inhibiting the PI3K/Akt and MAPK pathways, underscoring its potential as a novel therapeutic agent for ulcerative colitis.
Building similarity graph...
Analyzing shared references across papers
Loading...
Guangtao Zhang
Zhengxian Gao
Tianjie Xie
Combinatorial Chemistry & High Throughput Screening
Shenzhen University
Shenzhen University Health Science Center
Peking University Shenzhen Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Zhang et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69d893406c1944d70ce04429 — DOI: https://doi.org/10.2174/0113862073403084251212071505